Preveceutical Med Inc New
(PRVCF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -857 | -944 | -1,140 | -1,378 | -2,838 |
| Depreciation Amortization | 7 | 7 | 8 | 4 | 56 |
| Accounts receivable | -16 | 10 | -2 | 29 | 5 |
| Other Working Capital | 250 | 391 | 381 | 473 | 521 |
| Other Operating Activity | 304 | 317 | 582 | 532 | 2,304 |
| Operating Cash Flow | $-311 | $-220 | $-171 | $-340 | $48 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | N/A | N/A | 2 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -44 | -2 |
| Other Investing Activity | 0 | 0 | 1 | -44 | -2 |
| Investing Cash Flow | $-1 | $N/A | $1 | $-42 | $-2 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 235 | 70 | 168 | 37 | 47 |
| Debt Issued | N/A | 148 | N/A | 72 | 123 |
| Debt Repayment | -54 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 175 | N/A | N/A | N/A | 2 |
| Other Financing Activity | 0 | 0 | -5 | 0 | -34 |
| Financing Cash Flow | $356 | $218 | $163 | $109 | $138 |
| Exchange Rate Effect | -1 | -1 | 0 | 161 | -88 |
| Beginning Cash Position | 1 | 4 | 12 | 125 | 21 |
| End Cash Position | 43 | 1 | 4 | 13 | 117 |
| Net Cash Flow | $42 | $-3 | $-8 | $-112 | $96 |
| Free Cash Flow | |||||
| Operating Cash Flow | -311 | -220 | -171 | -340 | 48 |
| Capital Expenditure | -1 | N/A | N/A | 2 | N/A |
| Free Cash Flow | -313 | -220 | -171 | -338 | 48 |